HCW Biologics (HCWB) Enterprise Value (2020 - 2025)
HCW Biologics (HCWB) has disclosed Enterprise Value for 6 consecutive years, with -$1.1 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value fell 9.69% year-over-year to -$1.1 million, compared with a TTM value of -$1.1 million through Sep 2025, down 9.69%, and an annual FY2024 reading of -$4.7 million, down 30.03% over the prior year.
- Enterprise Value was -$1.1 million for Q3 2025 at HCW Biologics, up from -$2.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at $32.1 million in Q2 2021 and bottomed at -$38.9 million in Q4 2022.
- Average Enterprise Value over 5 years is -$12.2 million, with a median of -$10.0 million recorded in 2023.
- The sharpest move saw Enterprise Value soared 1113.24% in 2021, then crashed 2848.35% in 2025.
- Year by year, Enterprise Value stood at -$36.7 million in 2021, then fell by 6.03% to -$38.9 million in 2022, then skyrocketed by 90.77% to -$3.6 million in 2023, then tumbled by 30.03% to -$4.7 million in 2024, then skyrocketed by 76.53% to -$1.1 million in 2025.
- Business Quant data shows Enterprise Value for HCWB at -$1.1 million in Q3 2025, -$2.4 million in Q2 2025, and -$590524.0 in Q1 2025.